Clinical Trial

A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 20, 2024 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase Ib/II Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of IAP0971 in Patients with Advanced Malignant Tumors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-16.
Trial Details
NCT Number NCT06223841
Lead Sponsor SUNHO（China）BioPharmaceutical CO., Ltd.
Conditions Advanced Malignant Tumors
Enrollment 50 participants
Start Date 2024-03-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-02-20